ADI – Dementia Care and COVID-19
Access all of the content
Videos produced by and shared with kind authorisation of Alzheimer’s Disease International (ADI).
Professor Huali Wang, Executive Vice President of ADI’s member association in China, Alzheimer’s Disease Chinese (ADC), explains how China has addressed the specific challenges of people living with dementia during the COVID-19 outbreak, and how this advice can be used in other countries across the world.
See also an introduction from ADI’s Chief Executive, Paola Barbarino.
Please find more information online at www.alz.co.uk, including further useful COVID-19 resources.
Share this Video
Related Videos In COVID-19
Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction
Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms and investigations leading to the case report conclusions. The abstract entitled […]
Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination
Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that have been observed. The abstract entitled ‘Covid vaccine induced parkinsonism and cognitive dysfunction’ was presented […]
Raquel Gil-Gouveia, EAN 2022: Highlights in headache and migraine – Treatment advances, strategies for prevention, Anti-CGRP use in migraine, COVID-19
Headache is one of the most common nervous system disorders. In an interview with touchNEUROLOGY, Dr Raquel Gil-Gouveia (Hospital da Luz, Lisbon, Portugal) summarizes the ePoster session she chaired at EAN 2022, ranging from topics such as how COVID-19 has impacted on young people with headaches, the potential of new treatments such as eptinezumab and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!